Anemia y gammapatía oligoclonal en paciente con síndrome nefrótico

  1. Jiménez Reyes, Luisa
  2. Igea Gracia, Pilar 1
  3. Checa Daimiel, Laura Lucía 1
  4. Romero Calvo, Lidia
  5. Gómez Berrocal, Ana
  1. 1 Servicio de Medicina Interna, Hospital Central de la Defensa Gómez Ulla, Madrid, España
Revista:
Revista Española de Casos Clínicos en Medicina Interna (RECCMI)

ISSN: 2530-0792

Any de publicació: 2021

Títol de l'exemplar: Spanish Journal of Case Records in Internal Medicine

Volum: 6

Número: 2

Pàgines: 33-35

Tipus: Article

DOI: 10.32818/RECCMI.A6N2A12 DIALNET GOOGLE SCHOLAR lock_openAccés obert editor

Altres publicacions en: Revista Española de Casos Clínicos en Medicina Interna (RECCMI)

Objectius de Desenvolupament Sostenible

Resum

Visceral leishmaniasis is the most severe form of presentation of Leishmania infection. It is a multisystemic disease that often affects immunosuppressed patients. We present a case of a 72-year-old woman in chronic immunosuppressive therapy with steroids and cyclosporine who debuts with weight loss, asthenia, atypical pneumonia, splenomegaly, and polyclonal hypergammaglobulinemia with the diagnosis of visceral leishmaniasis and amastigotes of Leishmania in the bone marrow

Referències bibliogràfiques

  • - Dropulic LK, Lederman HM. Overview of Infections in the Immunocompromised Host. Microbiol Spectr. 2016 Aug;4(4). doi: https://doi.org/10.1128/microbiolspec.DMIH2-0026-2016.
  • - Aronson N, Herwaldt BL, Libman M, Pearson R, Lopez-Velez R, Weina P et al. Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2016; 63(12): e202-e264. doi: https://doi.org/10.1093/cid/ciw670.
  • - Silva Junior GB, Barros EJ, Daher Ede F. Kidney involvement in leishmaniasis-a review. Braz J Infect Dis. 2014; 18(4): 434-40. doi: https://doi.org/10.1016/j.bjid.2013.11.013.
  • - Herrador Z, Gherasim A, Jimenez BC, Granados M, San Martín JV, Aparicio P. Epidemiological changes in leishmaniasis in Spain according to hospitalization-based records, 1997-2011: raising awareness towards leishmaniasis in non-HIV patients. PLoS Negl Trop Dis. 2015; 9(3): e0003594. doi: https://doi.org/10.1371/journal.pntd.0003594.
  • - González E, Jiménez M, Hernández S, Martín-Martín I, Molina R. Phlebotomine sand fly survey in the focus of leishmaniasis in Madrid, Spain (2012-2014): seasonal dynamics, Leishmania infantum infection rates and blood meal preferences. Parasit Vectors. 2017; 10(1): 368. doi: https://doi.org/10.1186/s13071-017-2309-z.
  • - van Griensven J, Carrillo E, López-Vélez R, Lynen L, Moreno J. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect. 2014; 20(4): 286-99. doi: https://doi.org/10.1111/1469-0691.12556.
  • - Alvar J, Aparicio P, Aseffa A, Den Boer M, Cañavate C, Dedet JP et al. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev. 2008; 21(2): 334-59. doi: https://doi.org/10.1128/CMR.00061-07.
  • - Pittalis S, Nicastri E, Spinazzola F, Ghirga P, De Marco M, Paglia MG et al. Leishmania infantum leishmaniasis in corticosteroid--treated patients. BMC Infect Dis. 2006; 6: 177. doi: https://doi.org/10.1186/1471-2334-6-177.
Fuente de los datos: Dialnet